Search Within

Anas Younes

Formats
  1. Meeting Abstract (153)
  2. Journal Article (136)
  3. Book Section (13)
  4. Book Whole (4)
  5. Editorial (4)
  6. Review (4)
  7. Conference Paper (2)
  8. Research Letter (2)
  9. Correspondence (1)
  10. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (320)
  2. Department of Medicine (320)
  3. Executive Committee, Center for Hematologic Malignancies (320)
  4. Hematologic Malignancies, Division of (320)
  5. Lymphoma (320)
  6. Hematology-Oncology Fellows (98)

More Groups

People
  1. Andrew Zelenetz (89)
  2. Connie Batlevi (81)
  3. David Straus (74)
  4. Matthew Matasar (68)
  5. Anita Kumar (67)
  6. Paul Hamlin (67)

More People

Years
  1. 2024 (3)
  2. 2023 (7)
  3. 2022 (11)
  4. 2021 (13)
  5. 2020 (26)
  6. 2019 (53)

More Years

Publications
  1. Blood (91)
  2. Journal of Clinical Oncology (25)
  3. Hematological Oncology (22)
  4. Haematologica (16)
  5. British Journal of Haematology (13)
  6. Cancer Research (10)

More Publications

Publishers
  1. American Society of Hematology (99)
  2. American Society of Clinical Oncology (27)
  3. Wiley Blackwell (25)
  4. Nature Publishing Group (19)
  5. Springer (17)
  6. American Association for Cancer Research (16)

More Publishers

Results (320)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 trial testing single agent CUDC-907, a novel, oral dual inhibitor of histone deacetylase (HDAC) and PI3K: Initial assessment of patients with relapsed or refractory (RR) diffuse large B-Cell lymphoma (DLBCL), including double expressor (DE) lymphoma
    Meeting Abstract

    Younes, A.; Berdeja, J. G.; Patel, M. R.; Kelly, K. R.; Flinn, I. W.; Gerecitano, J. F.; Neelapu, S. S.; Copeland, A. R.; Akins, A.; Clancy, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • BET inhibitor CPI-0610 is well tolerated and induces responses in diffuse large B-cell lymphoma and follicular lymphoma: Preliminary analysis of an ongoing phase 1 study
    Meeting Abstract

    Abramson, J. S.; Blum, K. A.; Flinn, I. W.; Gutierrez, M.; Goy, A.; Maris, M.; Cooper, M.; O'Meara, M.; Borger, D.; Mertz, J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Hodgkin and non-Hodgkin lymphomas seen through their microenvironment: Impact on diagnosis, prognosis and innovative therapy
    Book Whole


    Future Medicine (2015)

    Fulltext@MSK | Save
  • Hodgkin and non-Hodgkin lymphomas seen through their microenvironment: Impact on diagnosis, prognosis and innovative therapy
    Book Whole


    Future Medicine (2015)

    Fulltext@MSK | Save
  • Targeting CD30 in patients with Hodgkin lymphoma
    Book Section

    Kumar, A.; Pileri, S.; Younes, A.; Engert, A.
    In Andreas, E.; Younes, A. (Eds.) Hodgkin Lymphoma: A Comprehensive Overview. 2nd ed (2015)

    Fulltext@MSK | Save
  • Other new agents for Hodgkin lymphoma
    Book Section

    Moskowitz, A. J.; Younes, A.
    In Andreas, E.; Younes, A. (Eds.) Hodgkin Lymphoma: A Comprehensive Overview. 2nd ed (2015)

    Fulltext@MSK | Save
  • Preface
    Book Section

    Andreas, E.; Younes, A.
    In Andreas, E.; Younes, A. (Eds.) Hodgkin Lymphoma: A Comprehensive Overview. 2nd ed (2015)

    Fulltext@MSK | Save
  • Hodgkin lymphoma: A comprehensive overview. 2nd ed
    Book Whole


    Springer (2015)

    Fulltext@MSK | Save
  • Hodgkin lymphoma microenvironment: Old and new therapeutic targets
    Book Section

    Batlevi, C. L.; Younes, A.
    In Carbone, A.; Younes, A. (Eds.) Hodgkin and Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (2015)

    Fulltext@MSK | Save
  • Prognostic significance of diffuse large B-cell lymphoma cell of origin: Seeing the forest and the trees
    Journal Article

    Younes, A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save